Live Quote · OTCORGSHealthcare· Biotechnology

Orgenesis Inc.

$0.05 88.33%($-0.35)
TickerSpark Score
35/100
Weak
73
Valuation
40
Profitability
10
Growth
24
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORGS research report →

52-Week Range0% of range
Low
$0.02
Current
$0.05
High
$5.89
Company Overviewwww.orgenesis.com

About the company

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform.

CEO
Vered Caplan
IPO
2012
Employees
146
HQ
Germantown, MD, US

Price Chart

-73.86% · this period
$1.53$0.77$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$241.40K
P/E
-0.02
P/S
0.46
P/B
-0.06
EV/EBITDA
-0.36
Div Yield
0.00%
Profitability
Gross Margin
-1080.19%
Op Margin
-10120.00%
Net Margin
-10445.47%
ROE
-1683.22%
ROIC
-3156.92%
Growth & Income
Revenue
$530.00K · -98.53%
Net Income
$-55,361,000 · -271.82%
EPS
$-1.91 · -223.73%
Op Income
$-53,636,000
FCF YoY
54.65%
Performance & Tape
52W High
$5.89
52W Low
$0.02
50D MA
$0.30
200D MA
$0.84
Beta
3.15
Avg Volume
1.94K

Get TickerSpark's AI analysis on ORGS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 5, 25MALIK ARIELother0
Dec 12, 24Adler Yaronother1,750
Dec 12, 24PELAVIN ADAMother1,250
Dec 12, 24PELAVIN ADAMother625
Dec 12, 24Nanda Ashishother1,835
Dec 12, 24NAGARAJ SANTHOSHother1,250
Dec 12, 24NAGARAJ SANTHOSHother625
Dec 12, 24Vider Itzhakother1,500
Dec 12, 24BHALAJI JAGANNATHANother1,250
Dec 12, 24BHALAJI JAGANNATHANother625
Coverage · ORGS

Our ORGS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ORGS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ORGS report →
Internal Compare

Similar companies

Peers in the same neighborhood.